Advances in Neurocardiology: Focus on Anticoagulation for Valvular Heart Disease With and Without Atrial Fibrillation-Reference-Cited by-同舟云学术

Advances in Neurocardiology: Focus on Anticoagulation for Valvular Heart Disease With and Without Atrial Fibrillation

Published:2022-12 Issue:12 Volume:53 Page:3763-3768
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Gurol M. Edip¹^ORCID,Sposato Luciano A.²³⁴^ORCID

Affiliation:

1. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (M.E.G.).

2. Departments of Clinical Neurological Sciences, Anatomy and Cell Biology, and Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry (L.A.S.), Western University, London, ON, Canada.

3. Heart and Brain Laboratory (L.A.S.), Western University, London, ON, Canada.

4. Robarts Research Institute (L.A.S.), Western University, London, ON, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference17 articles.

1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

2. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

3. RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial

4. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

5. Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal Cardiac Imaging in the Assessment of Patients Who Have Suffered a Cardioembolic Stroke: A Review;Journal of Cardiovascular Development and Disease;2023-12-31

2. Oral anticoagulation challenges and therapeutic dilemmas in the very elderly: to treat and how to treat octogenarians and nonagenarians?;Polish Archives of Internal Medicine;2023-05-25